Question

What is the EPS (earnings per share data)? 2015 Dr Cr Accounts Payable        999,210 Accounts...

What is the EPS (earnings per share data)?

2015
Dr Cr
Accounts Payable        999,210
Accounts Receivable     2,943,125
Accrued Liabilities - Other        508,643
Accrued Pension Liabilities        650,216
Accrued Restructuring Charges        126,000
Accrued Salaries, Wages and Commissions        281,364
Accumulated Other Comprehensive Income (Loss)        621,236
Accumulated Depreciation - Property, Plant & Equipment     1,829,634
Accumulated Post-Employment Benefit Obligation (long-term)        802,316
Additional Paid-in Capital, Common Stock        299,304
Additional Paid-in Capital, Preferred Stock                  75
Allowance for Doubtful Accounts        125,436
Bonds Payable        244,563
Cash and Cash Equivalents        401,236
Common Stock ($1.00 par value) authorized 900 million shares issued 300 million shares in 2016, 284 million in 2015        300,000
Cost of Goods Sold     3,000,235
Current Portion of Long-term Debt        720,125
Deferred Tax Assets (current)           62,596
Deferred Tax Liabilities (long-term)        229,000
Depreciation Expense        307,200
Dividends - Common        292,351
Dividends - Preferred             2,000
General & Administrative Expenses     1,732,429
Goodwill and Other Intangibles     3,212,491
Income Taxes Payable        246,002
Interest Expense        201,366
Interest Income           10,126
Investments in unconsolidated affiliated companies     1,235,000
Inventories        163,214
Long-term Debt     3,223,713
(Loss) Income from Discontinued Operations, net of tax           28,100
Preferred Stock ($10 par value) authorized 10 million shares issued 90,000 shares in 2016, 90,000 in 2015                900
Prepaid Expenses        141,029
Property, Plant and Equipment     2,943,216
Provision for income taxes        245,105
Research and Development Expenses        199,500
Restructuring Charges        199,506
Retained Earnings, beginning     2,960,256
Sales     8,430,061
Selling Expenses           19,365
Short-term Investments           20,000
Treasury Stock, at cost - 117,156,719 shares in 2016 and 108,822,953 shares in 2015     4,472,969
Unearned Revenues        456,325
22,443,269 22,443,269
Brady and Co.
Income Statement
As of December 31, 2015
Sales          8,430,061
Interest Income                10,126
Cost of Goods Sold          3,000,235
Gross Profit          5,439,952
Operating Expenses
Selling Expenses                19,365
General & Administrative Expenses          1,732,429
Research and Development Expenses              199,500
Restructuring Charges              199,506
Depreciation Expense              307,200
Total Operating Expenses          2,458,000
Operating Income          2,981,952
Interest Expense           (201,366)
Income from Continuing Operations          2,780,586
Provision for Income Tax           (245,105)
Discontinued Operations net of tax              (28,100)
Net Income 2,507,381
Preferred Dividends                  2,000
Net Income -Retained Earnings 2,505,381

Homework Answers

Answer #1
  • All working forms part of the answer
  • Earning per share = Net Income available to common stockholders/No. of weighted average common stock shares outstanding.
  • Net Income (from Income Statement) available to Common Stock holder (after Preference Dividend) = $ 2,505,381,000

No. of common stock shares issued = 300 million = 300,000,000 shares
(-) Treasury Stock shares = 117,156,719 shares

Weighted Average common stock shares outstanding = 300,000,000 – 117,156,719 = 182,843,281 shares.

  • Answer

Earning Per share = $ 2,505,381,000 / 182,843,281 shares.
= 13.70234….

Earning per share = $ 13.70 per share

Know the answer?
Your Answer:

Post as a guest

Your Name:

What's your source?

Earn Coins

Coins can be redeemed for fabulous gifts.

Not the answer you're looking for?
Ask your own homework help question
Similar Questions
Using the data for Brady and Co. provided in the sheet labeled "Trial Balance" prepare Income...
Using the data for Brady and Co. provided in the sheet labeled "Trial Balance" prepare Income Statement - multiple-step for fiscal years 2015. Include earnings per share data. 2015 Dr Cr Accounts Payable          999,210 Accounts Receivable        2,943,125 Accrued Liabilities - Other          508,643 Accrued Pension Liabilities          650,216 Accrued Restructuring Charges          126,000 Accrued Salaries, Wages and Commissions          281,364 Accumulated Other Comprehensive Income (Loss)            621,236 Accumulated Depreciation - Property, Plant & Equipment       1,829,634 Accumulated Post-Employment...
My balance sheet does not balance please correct the missing information from trial balance and correct...
My balance sheet does not balance please correct the missing information from trial balance and correct the balance sheet below. Trial Balance 2015 Dr Cr Accounts Payable          999,210 Accounts Receivable        2,943,125 Accrued Liabilities - Other          508,643 Accrued Pension Liabilities          650,216 Accrued Restructuring Charges          126,000 Accrued Salaries, Wages and Commissions          281,364 Accumulated Other Comprehensive Income (Loss)            621,236 Accumulated Depreciation - Property, Plant & Equipment       1,829,634 Accumulated Post-Employment Benefit Obligation (long-term)          802,316 Additional...
Refine Assumptions for Dividend and Retained Earnings Forecast Provided below is FY2016 information for Medtronic PLC....
Refine Assumptions for Dividend and Retained Earnings Forecast Provided below is FY2016 information for Medtronic PLC. Medtronic plc Consolidated Statement of Income ($ millions) Apr. 29, 2016 Net sales $29,277 Costs and expenses Cost of products sold 9,142 Research and development expenses 2,224 Selling, general, and administrative expense 9,469 Special charges (gains), net 70 Restructuring charge, net 290 Certain litigation charges, net 26 Acquisition-related items 283 Amortization of intangiable assets 1,931 Other expense, net 107 Operating profit 5,735 Interest expense,...
Refine Assumptions for Dividend and Retained Earnings Forecast Provided below is FY2016 information for Medtronic PLC....
Refine Assumptions for Dividend and Retained Earnings Forecast Provided below is FY2016 information for Medtronic PLC. Medtronic plc Consolidated Statement of Income ($ millions) Apr. 29, 2016 Net sales $29,277 Costs and expenses Cost of products sold 9,142 Research and development expenses 2,224 Selling, general, and administrative expense 9,469 Special charges (gains), net 70 Restructuring charge, net 290 Certain litigation charges, net 26 Acquisition-related items 283 Amortization of intangiable assets 1,931 Other expense, net 107 Operating profit 5,735 Interest expense,...
Refine Assumptions for PPE Forecast Provided below is FY2016 information for Medtronic PLC. Medtronic plc Consolidated...
Refine Assumptions for PPE Forecast Provided below is FY2016 information for Medtronic PLC. Medtronic plc Consolidated Statement of Income ($ millions) Apr. 29, 2016 Net sales $29,499 Costs and expenses Cost of products sold 9,142 Research and development expenses 2,224 Selling, general, and administrative expense 9,469 Special charges (gains), net 70 Restructuring charge, net 290 Certain litigation charges, net 26 Acquisition-related items 283 Amortization of intangiable assets 1,931 Other expense, net 107 Operating profit 5,957 Interest expense, net 955 Income...
Refine Assumptions for Dividend and Retained Earnings Forecast Following are the income statement and balance sheet...
Refine Assumptions for Dividend and Retained Earnings Forecast Following are the income statement and balance sheet for Medtronic PLC. Consolidated Statement of Income ($ millions) For Fiscal Year Ended April 26, 2019 Net sales $30,557 Costs and expenses Cost of products sold 9,155 Research and development expenses 2,330 Selling, general, and administrative expense 10,418 Amortization of intangible assets 1,764 Restructuring charges, net 198 Certain litigation charges, net 166 Other operating expense, net 258 Operating profit (loss) 6,268 Other nonoperating income,...
Please Give a Horizontal Analysis for CVS and Walgreens CVS Balance Sheet All numbers in thousands...
Please Give a Horizontal Analysis for CVS and Walgreens CVS Balance Sheet All numbers in thousands Period Ending 12/31/2017 12/31/2016 12/31/2015 Current Assets Cash And Cash Equivalents 1,696,000 3,371,000 2,459,000 Short Term Investments 111,000 87,000 88,000 Net Receivables 13,181,000 12,164,000 11,888,000 Inventory 15,296,000 14,760,000 14,001,000 Other Current Assets 945,000 660,000 722,000 Total Current Assets 31,229,000 31,042,000 29,158,000 Long Term Investments - - - Property Plant and Equipment 10,292,000 10,175,000 9,855,000 Goodwill 38,451,000 38,249,000 38,106,000 Intangible Assets 13,630,000 13,511,000 13,878,000 Accumulated...
Plese give a conclusion and recommendation for investment for CVS & Walgreens. Please reposnd in a...
Plese give a conclusion and recommendation for investment for CVS & Walgreens. Please reposnd in a paragraph or four or more senetences. CVS Balance Sheet All numbers in thousands Period Ending 12/31/2017 12/31/2016 12/31/2015 Current Assets Cash And Cash Equivalents 1,696,000 3,371,000 2,459,000 Short Term Investments 111,000 87,000 88,000 Net Receivables 13,181,000 12,164,000 11,888,000 Inventory 15,296,000 14,760,000 14,001,000 Other Current Assets 945,000 660,000 722,000 Total Current Assets 31,229,000 31,042,000 29,158,000 Long Term Investments - - - Property Plant and Equipment...
At year-end 2015, Wallace Landscaping’s total assets were $1.9 million and its accounts payable were $435,000....
At year-end 2015, Wallace Landscaping’s total assets were $1.9 million and its accounts payable were $435,000. Sales, which in 2015 were $2.5 million, are expected to increase by 20% in 2016. Total assets and accounts payable are proportional to sales, and that relationship will be maintained. Wallace typically uses no current liabilities other than accounts payable. Common stock amounted to $465,000 in 2015, and retained earnings were $300,000. Wallace has arranged to sell $80,000 of new common stock in 2016...
At year-end 2015, Wallace Landscaping’s total assets were $1.6 million and its accounts payable were $375,000....
At year-end 2015, Wallace Landscaping’s total assets were $1.6 million and its accounts payable were $375,000. Sales, which in 2015 were $2.5 million, are expected to increase by 15% in 2016. Total assets and accounts payable are proportional to sales, and that relationship will be maintained. Wallace typically uses no current liabilities other than accounts payable. Common stock amounted to $375,000 in 2015, and retained earnings were $320,000. Wallace has arranged to sell $60,000 of new common stock in 2016...